<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T05:15:40Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/30531" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/30531</identifier><datestamp>2026-09-24T02:33:36Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor">Frey, Benicio</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author">Ali, Mohammad</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Neuroscience</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2024-11-05T16:52:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2024-11-05T16:52:36Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2024-11</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/30531</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/15006</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Introduction: Bipolar disorder (BD) has widely been reported to display deficits in brain&#xd;
morphology, specifically abnormalities in white matter (WM) and myelin content. These&#xd;
deficits have been hypothesized to underlie cognitive dysfunction in domains such as&#xd;
verbal memory and executive function, which stresses the need to better understand the&#xd;
pathophysiology of these deficits and BD. Blood-based biomarkers provide an accessible&#xd;
route to analyze biological differences observed in BD compared to healthy control (HC),&#xd;
such as WM deficits. In this thesis, we first describe the extant literature thus far that has investigated any blood-based biomarkers related to WM and myelin content in BD to&#xd;
demonstrate the associations that have been reported to stress the possibility of using&#xd;
blood-based biomarkers as a proxy for WM deficits. We then expand on the literature by&#xd;
examining the association between peripheral neurofilament light chain (NfL) and&#xd;
intracortical myelin content (ICM). We then conclude by examining a novel biomarker,&#xd;
mesencephalic astrocyte-derived neurotrophic factor (MANF), which has been shown to&#xd;
reduce endoplasmic reticulum (ER) stress in BD. ER stress has previously been observed&#xd;
to reduce cellular resilience and increase cell death in BD.&#xd;
Results: Based on our analysis, a wide range of blood-based biomarkers, including&#xd;
markers within the innate immune response, cytokines, and oxidative stress, were&#xd;
associated with neuroimaging markers of WM and myelin content in BD. Furthermore,&#xd;
NfL was associated with areas of the brain that have previously been observed to display&#xd;
deficits in ICM. In addition, NfL was significantly increased in BD compared to HC, providing further evidence of a neurodegenerative process in BD. Lastly, MANF was reduced in individuals in a depressive phase of BD compared to HC and euthymic individuals, suggesting an inadequate response to ER stress and further supporting the&#xd;
literature that BD is associated with increased ER stress.&#xd;
Conclusion: The results of this thesis underscore the significant role of blood-based&#xd;
biomarkers in better understanding BD pathophysiology. The identification of key&#xd;
differences in blood-based biomarkers in BD compared to HC, and their association with&#xd;
brain morphology, particularly myelin integrity, can help to improve our understanding of&#xd;
BD and encourages further studies. This thesis expands on current literature and provides novel findings regarding peripheral markers in BD pathophysiology, and that blood-based biomarkers may serve as a proxy for central changes.</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degreetype" lang="en_US">Dissertation</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="layabstract" lang="en_US">Bipolar disorder (BD) is a mental health disorder characterized by rotating periods&#xd;
of depression and mania, which is when the individual experiences symptoms of extreme&#xd;
energy or irritability. Scientific studies investigating BD have shown abnormalities in the&#xd;
brain, compared to healthy individuals. These changes have been related to many deficits&#xd;
observed in BD such as cognitive impairments. Changes in the brain can be difficult to&#xd;
assess due to the need of medical imaging such as magnetic resonance imaging. As a&#xd;
result, it is crucial we find alternative methods to assess these changes. Biological&#xd;
markers in the blood may be able to provide an accessible and comparatively cheaper way&#xd;
to attempt to analyze changes in the brain. This thesis explores the association between&#xd;
blood-based biomarkers and changes in the brain. Specifically, we discuss in detail all the&#xd;
markers that have been studied in relation to changes in white matter and myelin content&#xd;
and further introduce two additional markers that were different in individuals with BD&#xd;
compared to healthy individuals. This thesis provides preliminary data that can help to&#xd;
better understand the biological basis of BD, specifically how certain mechanisms can&#xd;
potentially be associated with changes in the brain and how to evaluate these alterations&#xd;
through blood.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Blood-based biomarkers</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Bipolar Disorder</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Myelin</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Endoplasmic Reticulum Stress</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Neurofilament Light Chain</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Neurodegeneration</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Intracortical myelin</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Mesencephalic Astrocyte-derived Neurotrophic Factor</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Analysis of Blood Based Biomarkers in Bipolar Disorder</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">Thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>